TripSit · 1B-LSD

正文中文为机器翻译，仅供参考；专业内容以折叠的原文为准。

详情

别名

1b

分类

tentative research-chemical 致幻剂

剂量说明

NOTE: At the time of this chemical's release, the manufacturers claimed 1B-LSD was expected to be slightly less potent than 1P-LSD, supposedly owing to the increased mass of the butanoyl group over the propionyl group, however anecdotes seem to indicate approximate equipotency to 1P-LSD.

后遗时间

6-24 小时

剂量

口服

常规

50-125ug

轻度

25-50ug

强效

125-250ug

持续时间

8-12 小时

起效时间

45-90 分钟

名称

1b-lsd

通用名

1B-LSD

属性

后遗效应

6–24 小时

别名

1b

分类

tentative research-chemical 致幻剂

剂量

Oral Light: 25-50ug Common: 50-125ug's Strong: 125-250ug's. | NOTE: At the time of this chemical's release, the manufacturers claimed 1B-LSD was expected to be slightly less potent than 1P-LSD, supposedly owing to the increased mass of the butanoyl group over the propionyl group, however anecdotal reports seem to indicate approximate equipotency to 1P-LSD.

持续

8–12 小时

起效

45–90 分钟

摘要

1B-LSD (1-butanoyl-lysergic acid diethylamide) is an LSD analogue which appears to be about as potent as 1P-LSD (slightly more potent than LSD) and has a slightly shorter duration than that of LSD, again thought to be about the same as 1P-LSD. Released in late 2018, and marketed agressively as a replacement for 1P-LSD. 1B-LSD does not yet have a clearly established safety profile,